Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy - Université de Reims Champagne-Ardenne Access content directly
Journal Articles Clinical Pharmacokinetics Year : 2024

Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy

Naïm Bouazza
  • Function : Author
Saïk Urien
  • Function : Author
Frantz Foissac
  • Function : Author
Laure Choupeaux
  • Function : Author
Gabrielle Lui
  • Function : Author
Léo Froelicher Bournaud
  • Function : Author
Steeve Rouillon
  • Function : Author
Yi Zheng
  • Function : Author
Emmanuelle Bardin
  • Function : Author
Nathalie Stremler
  • Function : Author
Tiphaine Bihouee
  • Function : Author
Emmanuelle Coirier-Duet
  • Function : Author
Christophe Marguet
  • Function : Author
Eric Deneuville
  • Function : Author
Muriel Laurans
  • Function : Author
Philippe Reix
  • Function : Author
Michèle Gerardin
  • Function : Author
Marie Mittaine
  • Function : Author
Ralph Epaud
  • Function : Author
Caroline Thumerelle
  • Function : Author
Laurence Weiss
  • Function : Author
Romain Berthaud
  • Function : Author
Michaela Semeraro
  • Function : Author
Jean-Marc Treluyer
  • Function : Author
Sihem Benaboud
  • Function : Author
Isabelle Sermet-Gaudelus
  • Function : Author
No file

Dates and versions

hal-04456690 , version 1 (14-02-2024)

Identifiers

Cite

Naïm Bouazza, Saïk Urien, Frantz Foissac, Laure Choupeaux, Gabrielle Lui, et al.. Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized Therapy. Clinical Pharmacokinetics, 2024, ⟨10.1007/s40262-023-01342-3⟩. ⟨hal-04456690⟩

Collections

HCL URCA P3CELL
13 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More